 BOULDER, Colo., April 23, 2020 GLOBE NEWSWIRE -- miRagen Therapeutics, Inc. MGEN, a clinical-stage biopharmaceutical company focused on the discovery and development of RNA-targeted therapies, today announced it will report its first quarter 2020 financial results after the financial markets close on Thursday, May 7, 2020. To access the live webcast, please go to the investors section of miRagens website at Following the live webcast, an archived version of the call will be available on the website. 